Company Overview
Aptamer Therapeutics Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Wednesday 28 May 2014, so this is a well established company. Aptamer Therapeutics Limited has been in business for 11 years and 10 months. The accounts status is total exemption full and the accounts are next due on Tuesday 31 March 2026.
Registered Address

Windmill House, Innovation Way, York, YO10 5BR
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameAPTAMER THERAPEUTICS LIMITED
Company Number09059325
Registered Office AddressWindmill House
 Innovation Way
 YO10 5BR
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date28/05/2014
Accounting Reference Date Day30
Accounting Reference Date Month6
Accounts Next Due Date31/03/2026
Accounts Last Made Up Date30/06/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date25/06/2017
Returns Last Made Up Date28/05/2016
Previous Company NameChanged Date
APTASORT LIMITED25 May 2019
Directors & Members
Show Resigned
David Bunka - Director
(British, 48 years old, born January 1978)
Appointed 18 October 2021
 Active
Arron Tolley - Director
(British, 49 years old, born November 1977)
Appointed 21 August 2023
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
David Bunka
APTASORT LIMITED
Arron Tolley
APTAMER DIAGNOSTICS LIMITED
APTAMER GROUP PLC
APTAMER SOLUTIONS LIMITED
APTASORT LIMITED
Balance Sheet Unlock full report
Accounts Date 30-Jun-2024 31-Mar-2020 31-Mar-2019
Balance Sheet
Fixed Assets 122,602 122,602 0
Current Assets 36,317 36,317 9
Creditors Due Within One Year 101,366 101,366 2,649
Working Cap -65,049 -65,049 -2,640
Total Assets Less Current Liabilities 57,553 57,553 -2,640
Long-term Liabilities 153,712 153,712 0
Net Assets -96,159 -96,159 -2,640
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds -96,159 -96,159 -2,640
Common Size Financial Analysis Unlock full report
Accounts Date 30-Jun-2024 31-Mar-2020 31-Mar-2019
Tangible Fixed Assets - - -
Fixed Assets 77.1% 77.1% 0.0%
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets 22.9% 22.9% 100.0%
Creditors Due Within One Year 63.8% 63.8% 29433.3%
Net Current Assets Liabilities -40.9% -40.9% -29333.3%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds -60.5% -60.5% -29333.3%
Capital Employed - - -
Total Assets Less Current Liabilities 36.2% 36.2% -29333.3%
Financial Ratio Analysis Unlock full report
Accounts Date 30-Jun-2024 31-Mar-2020 31-Mar-2019
Liquidity Ratio 0.4 0.4 0.0
Solvency Ratio 0.6 0.6 0.0
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 30-Jun-2024 31-Mar-2020 31-Mar-2019
Assets 158,919 158,919 9
Debt 255,078 255,078 2,649
Net Assets/Debt -96,159 -96,159 -2,640

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.Current debt exceeded short term liquid assets as at the balance sheet date. We would normally view this in the context of other profitability and solvency indicators. Total reserves including retained profitability and movement in reserves has some deficiency. The balance sheet net assets figure is negative. The latest accounts are not up-to-date. Later accounts are now overdue. Late filing is not a positive factor. Analysis based on the latest figures available must be taken in the context that the figures are not up-to-date.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around YO10 5BR
ADVANCE HE
Advance He Innovation Way, York Science Park, York, YO10 5BR
Document Filings
Confirmation statement made on 28 May 2025 with no updates
Confirmation statement made on 28 May 2024 with no updates
Termination of appointment of Robert Quinn as a director on 21 August 2023
Appointment of Dr Arron Craig Tolley as a director on 21 August 2023
Confirmation statement made on 28 May 2023 with updates
Change of details for Aptamer Group Limited as a person with significant control on 12 October 2022
Appointment of Dr Robert Quinn as a director on 16 May 2023
Termination of appointment of Arron Craig Tolley as a director on 16 May 2023
Registered office address changed from Aptamer Therapeutics Ltd Second Floor, Bio Centre Innovation Way Heslington York North Yorkshire YO10 5NY United Kingdom to Windmill House Innovation Way York YO10 5BR on 12 October 2022
Termination of appointment of Eleanor Brown as a director on 13 June 2022
Confirmation statement made on 28 May 2022 with no updates
Cessation of Arron Craig Tolley as a person with significant control on 22 December 2021
Director's details changed for Mrs Eleanor Courtman-Stock on 17 January 2022
Appointment of Dr David Harry John Bunka as a director on 18 October 2021
Appointment of Mrs Eleanor Courtman-Stock as a director on 18 October 2021
Current accounting period extended from 31 March 2021 to 30 June 2021
Confirmation statement made on 28 May 2021 with no updates
Registered office address changed from Suite 2.78 - 2.91 Bio Centre Innovation Way Heslington York North Yorkshire YO10 5NY United Kingdom to Aptamer Therapeutics Ltd Second Floor, Bio Centre Innovation Way Heslington York North Yorkshire YO10 5NY on 16 December 2020
Confirmation statement made on 28 May 2020 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free